Nanoparticle “Solar Cells” Restore Light Sensitivity in Blind Retinas

Summary:

An international team of researchers has developed injectable, hollow semiconducting nanoparticles that act as microscopic light receptors inside blind eyes. When illuminated, these particles wirelessly trigger remaining retinal nerve cells to send visual signals to the brain, restoring measurable light responses in models of retinitis pigmentosa.

Key Facts:

• Microscopic Photoreceptor Substitutes: The hollow nanoparticles (roughly 300 nm in diameter) are made from graphitic carbon nitride and mimic plant chloroplasts to capture visible light and stimulate neighboring retinal cells without requiring genetic modification.
• Signals Reach the Brain: In blind mice with advanced retinitis pigmentosa, injecting these nanoparticles close to retinal ganglion cells produced detectable light-induced signaling in the brain’s visual cortex and prompted observable behavioral changes.
• Mutation-Independent Approach: Unlike gene therapies that target specific genetic mutations or optogenetics that requires viral vectors, this physical wireless interface utilizes the surviving native nerve cells of degenerated retinas regardless of underlying disease mutations.

Source: Aarhus University

In neurodegenerative blinding diseases such as retinitis pigmentosa, the eye’s primary light-capturing photoreceptors gradually deteriorate and die. However, deeper down in the retinal circuitry, secondary nerve cells, such as retinal ganglion cells, often remain healthy and functional. For years, neuroengineers have sought a way to recruit these surviving neurons to bypass lost photoreceptors entirely.

Now, a multi-institutional study published in Nature Biomedical Engineering demonstrates a significant step forward: injectable, light-sensitive nanoparticles capable of restoring light perception to blind retinas.

Led by Associate Professor Menglin Chen at Aarhus University, the international research team engineered hollow nanoparticles composed of graphitic carbon nitride, a semiconductor highly sensitive to visible light. Measuring approximately 300 nanometers wide, the structures take architectural inspiration from plant chloroplasts to harvest photon energy efficiently.

“When we started, our fundamental question was whether we could create a material that could act as a wireless interface between light and living cells. We can now see that the particles are able to activate nerve cells in blind retinas. That brings us closer to our long-term goal of developing a new type of retinal prosthesis,” said Dr. Chen.

Activating the Visual Pathway in Blind Eyes

When exposed to light, the graphitic carbon nitride particles induce local physical and chemical reactions in their immediate environment, generating signals that stimulate adjacent living cells.

To test whether this physical interface could substitute for lost photoreceptors, the team injected the particles into the eyes of mice suffering from advanced retinitis pigmentosa. The nanoparticles settled on the retinal surface, resting close to retinal ganglion cells,the primary conduits that relay visual information to the brain.

Upon illumination, the researchers detected clear evoked electrical activity in the mice’s visual cortex. Furthermore, the blind mice displayed measurable behavioral adjustments in response to light exposure. The team verified the finding across species, showing that the nanoparticles could also stimulate ganglion cells in isolated retinal tissue harvested from pigs.

“What is particularly interesting is that we are trying to make use of the nerve cells that still function in the retina. Instead of genetically modifying these cells, we use the nanoparticles to create a new connection between light and the nerve cells. In this way, we are trying to make a blind retina respond to light again,” said Chen.

A Mutation-Agnostic Horizon for Vision Restoration

Current restorative vision strategies face significant clinical trade-offs. Traditional electronic retinal implants require invasive ocular surgeries and bulky hardware. Gene therapies can fix failing tissue but are limited to specific known genetic mutations, while optogenetics requires genetically editing surviving neurons using viral delivery systems.

“Once the photoreceptors are lost, the options for restoring light sensitivity are still very limited, and each approach in development carries its own constraint,” explained co-author and retina specialist Henri Leinonen. “That is why it is worth testing strategies that work independently of the cause of the disease. What we show here is a light-evoked response in a degenerated retina, which is an early step rather than a finished prosthesis.”

While the technology does not yet restore high-acuity, normal vision, it proves that microscopic “photovoltaic” particles can establish an effective wireless link with degenerated mammalian neural circuits. The research team has filed international patents for the technology and is currently investigating long-term ocular biocompatibility, delivery optimization, and stability as they work toward eventual human clinical trials.

Editorial Notes:

• This article was edited by a Neuroscience News editor.
• Journal paper reviewed in full.
• Additional context added by our staff.

About this Genetics and Neuroregeneration Research:

• Media Contact: Jesper Bruun
• Source: Aarhus University
• Image Credit: Image credited to Neuroscience News
• Original Research is Open Access: Nature Biomedical Engineering (September 22, 2026). “Biomimetic graphitic carbon nitride nanoparticles for multiscale photomodulation and therapeutic intervention.” Authors: Christoph Alexander Müller, Kjeld Kaj Klompmaker, Yuge Zhang, Jing Zhang, Anna Kalatanova, Pengjiu Li, Lingyuan Meng, Jesper Guldsmed Madsen, Thomas Stax Jakobsen, Asbjørn C. Jørgensen, Anne Louise Askou, Yonglun Luo, Lin Lin, Sara Vogt Bleshøy, Georgios Bolis, Ge Huang, Wen Li, Rasmus Schmidt Davidsen, Toke Bek, Nikos S. Hatzakis, Thomas J. Corydon, Henri Leinonen, Bozhi Tian, Mingdong Dong & Menglin Chen.
• DOI: 10.1038/s41551-026-01773-w

Abstract

Biomimetic graphitic carbon nitride nanoparticles for multiscale photomodulation and therapeutic intervention

Most organic matter on Earth originates from the conversion of solar energy through photosynthesis in chloroplasts. Here, drawing inspiration from photosynthesis, we develop hollow-sphere graphitic carbon nitride nanoparticles (hg-C₃N₄ NPs) that can modulate biological activity from subcellular processes to whole‑tissue function.

The homogeneous hg-C₃N₄ NPs show responsiveness to light via both photoelectrochemical and photothermal mechanisms and can be spontaneously internalized with excellent cytocompatibility. Using a focusing laser, the hg-C₃N₄ NPs enable intracellular optical stimulation with subcellular resolution, inducing calcium-transient release in multiple cells and propagation in primary cardiomyocytes and cardiac fibroblasts.

At the multicellular scale, optical pacing and synchronization of cardiomyocyte beating is readily achieved by light-emitting diodes. Further, we demonstrate that hg-C₃N₄ nanoparticles can be safely delivered and elicit measurable cortical and behavioural light responses in a model of advanced retinal degeneration.

The application of hg-C₃N₄ NPs to porcine retinal tissue ex vivo confirms their modulation capability to directly activate retinal ganglion cell activity under light-emitting diode photostimulation.

Taken together, hg-C₃N₄ NPs represent a versatile tool to address complex biomedical challenges through subcellular, intercellular and tissue-level photo-modulation.